Success Metrics

Clinical Success Rate
99.0%

Based on 98 completed trials

Completion Rate
99%(98/99)
Active Trials
4(3%)
Results Posted
43%(42 trials)
Terminated
1(1%)

Phase Distribution

Ph phase_3
11
9%
Ph phase_4
55
43%
Ph early_phase_1
2
2%
Ph phase_2
7
6%
Ph not_applicable
43
34%

Phase Distribution

2

Early Stage

7

Mid Stage

66

Late Stage

Phase Distribution118 total trials
Early Phase 1First-in-human
2(1.7%)
Phase 2Efficacy & side effects
7(5.9%)
Phase 3Large-scale testing
11(9.3%)
Phase 4Post-market surveillance
55(46.6%)
N/ANon-phased studies
43(36.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

95.1%

98 of 103 finished

Non-Completion Rate

4.9%

5 ended early

Currently Active

4

trials recruiting

Total Trials

127

all time

Status Distribution
Active(5)
Completed(98)
Terminated(5)
Other(19)

Detailed Status

Completed98
unknown19
Withdrawn4
Recruiting4
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
127
Active
4
Success Rate
99.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (1.7%)
Phase 27 (5.9%)
Phase 311 (9.3%)
Phase 455 (46.6%)
N/A43 (36.4%)

Trials by Status

completed9877%
not_yet_recruiting11%
withdrawn43%
recruiting43%
terminated11%
unknown1915%

Recent Activity

Clinical Trials (127)

Showing 20 of 127 trialsScroll for more
NCT05887375Phase 4

Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery

Completed
NCT07404579Phase 2

Safety and Efficacy of HRS-9190 Compared to Rocuronium for Bolus Maintenance in Adults

Recruiting
NCT07464288Not Applicable

Effect of Neuromuscular Block Depth on Driving Pressure and Postoperative Respiratory Events in Abdominal Surgeries

Not Yet Recruiting
NCT07203287Phase 4

Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease

Recruiting
NCT04760912Phase 4

General Anesthesia With and Without Muscle Relaxation and Muscle Strength Recovery

Completed
NCT06564857Phase 4

Remifentanil Versus Rocuronium for Optimizing Video Laryngoscopy-assisted Tracheal Intubation

Recruiting
NCT05279898Not Applicable

Perioperative Multimodal General AnesTHesia Focusing on Specific CNS Targets in Patients Undergoing carDiac surgERies

Completed
NCT06225466Phase 4

Muscle Relaxation for Pediatric Adenotonsillectomy

Completed
NCT07064408Not Applicable

Subanesthetic Esketamine for Hemodynamic Stability and Recovery in Elderly Thoracic Surgery Patients

Completed
NCT04821817Not Applicable

Peribulbar Rocuronium in Adult Strabismus Surgery

Completed
NCT06707532Not Applicable

The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)

Recruiting
NCT05596227Not Applicable

Ultrasound Guided Erector Spinae Block vs Thoracolumbar Interfascial Plane Block

Completed
NCT05909696Not Applicable

Median Effective Dose of Rocuronium for the Prevention of Myofibrillation Caused by the Injection of Succinylcholine

Completed
NCT02631135Phase 4

Cognitive Functions After TIVA With Dexmedetomidine

Completed
NCT04868409Phase 4

Intubating Conditions During Rapid Sequence Induction in Elderly With Either Suxamethonium 1.0 mg/kg or Rocuronium 1.0 mg/kg

Completed
NCT03939923Phase 4

Role of Sugammadex as Reversal Agent in Patients Extubated Immediately After Isolated Coronary Artery Bypass Grafting Surgery

Completed
NCT03529201Not Applicable

QLB After Nephrectomy

Completed
NCT05423951Not Applicable

Effect of Remimazolam and Propofol on Hemodynamic Stability During Anesthesia Induction in OPCAB Patients

Completed
NCT05681611

Effect of Rocuronium on BIS Values

Completed
NCT02589691Phase 4

Neuromuscular-Blocking Agents and Hypoxemia During Intubation in Infants (ROC-HYPOX)

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
127